Enjoy complimentary customisation on priority with our Enterprise License!
The Preclinical Isolated Organ Perfusion System Market size is estimated to grow by USD 137.63 million at a CAGR of 4.86% between 2023 and 2028.
Preclinical Isolated Organ Perfusion System Market Share
For More Highlights About this Report, Download Free Sample in a Minute
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
One of the key factors driving the preclinical isolated organ perfusion system market growth is the increasing prevalence of chronic diseases. Isolated organ perfusion systems are extensively utilized in preclinical research to study organ-targeted delivery of drugs and the physiology and therapeutic interventions of drugs on isolated organs. The increasing prevalence of chronic conditions such as cancer, cardiovascular diseases, and respiratory diseases across the world is contributing to the market growth.
Moreover, the rise in demand for new drugs will increase drug discovery activities, such as pharmacology and physiology studies, related to these diseases. As a result, there is an increasing adoption of isolated organ perfusion systems used to study the pharmacological effect of a new drug on isolated organs. Hence, such factors are expected to positively impact the market. Therefore, it is expected to drive market growth during the forecast period.
The growth of the preclinical isolated organ perfusion system market is driven by the increasing investment in research and development (R&D), particularly in preclinical research. Pharmaceutical companies are significant end-users of isolated organ perfusion systems, employing them as crucial tools in studying drug toxicity and evaluating the impact of new drug molecules on targeted organs.
Additionally, the growth in drug discovery and preclinical research activities is fueled by the rising R&D investments from key market players in the pharmaceutical industry. This, in turn, contributes significantly to the expansion of the preclinical isolated organ perfusion system market. The market is further propelled by the robust drug pipeline at various development stages, including the preclinical stage, coupled with ongoing R&D investments by companies, forecasting sustained growth throughout the forecast period.
The elevated expense associated with isolated organ perfusion systems presents a significant obstacle to the growth of the preclinical isolated organ perfusion system market. The increasing demand for isolated organ studies, particularly in preclinical research, has driven the adoption of these systems. However, the high cost poses a notable challenge to market expansion. The pricing of isolated organ perfusion systems varies based on factors such as organ type, brand, and quality, typically falling within the range of USD30,000 to USD35,000.
Furthermore, the product's price fluctuates depending on domestic or international market rates, with variations linked to the specific organ under study. Certain organs may necessitate additional equipment for studying their specialized functions, such as a ventilator for isolated perfused lungs. Consequently, these factors impede market growth throughout the forecast period.
The industrial laboratories and CROs segment is estimated to witness significant growth during the forecast period. This segment is one of the main organizations that are involved in drug discovery, research, design, and development. In addition, these organizations have the infrastructure required to conduct preclinical and clinical studies for testing various drug candidates. The rising investment of pharmaceutical companies in drug discovery and the increase in outsourcing activities to CROs is fuelling the growth of this segment.
Get a glance at the market contribution of various segments Download the PDF Sample
The industrial laboratories and CROs segment was the largest segment and was valued at USD 264.88 million in 2018. Moreover, pharma and biotech companies are primarily involved in the discovery and development of drugs for a wide array of therapeutic applications. In addition, the increasing prevalence of chronic diseases, such as cardiovascular diseases and respiratory disorders, drives the demand for new drug discovery among these end-users. Furthermore, isolated organ perfusion systems are used to study the pharmacology of new drugs on isolated organs. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The North American preclinical isolated organ perfusion system market is poised for moderate growth due to factors like key vendor presence, technological advancements, increased funding in life science research, and the presence of established pharmaceutical companies and research institutes. Key vendors, including Harvard Bioscience Inc., Radnoti LLC, and emka TECHNOLOGIES, will drive market expansion. Adoption of advanced technologies, such as isolated organ perfusion systems, in preclinical research, especially in the US, a major revenue contributor, will further propel market growth.
In North America, the demand for laboratory equipment has increased with the presence of global and local pharmaceutical companies like Bristol-Myers Squibb, Merck and Co., Amgen Inc., Pfizer Inc., and Johnson and Johnson. These companies, focusing on R&D for new drug molecules, contribute to the rising demand for isolated organ perfusion systems used in pharmacological studies during preclinical research.Moreover, the market will be fueled by the increasing prevalence of chronic diseases and the demand for organ transplants. Isolated organ perfusion is crucial for developing organ preservation methods and studying organ viability before transplantation, aligning with the growing demand for organ transplantation in North America.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
ADInstruments Pty Ltd: The company offers preclinical isolated organ perfusion systems such as the Isolated Perfused Rodent Liver Foundation System which provides the glassware for perfusing an isolated rodent liver to maintain its hepatic function.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Preclinical Isolated Organ Perfusion System Market Scope |
|
Report Coverage |
Details |
Page number |
156 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.86% |
Market growth 2024-2028 |
USD 137.63 million |
Market structure |
Concentrated |
YoY growth 2023-2024(%) |
3.8 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 36% |
Key countries |
US, Canada, Germany, China, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
ADInstruments Pty Ltd., ALA Scientific Instruments Inc., emka TECHNOLOGIES, Harvard Bioscience Inc., MDE GmbH, Radnoti LLC, World Precision Instruments, and XVIVO Perfusion AB |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.